{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:09:02Z","timestamp":1792660142731,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002651","name":"Barth Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002651","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jpeds.2019.09.074","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T09:12:05Z","timestamp":1573549925000},"page":"139-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["A Bayesian Analysis to Determine the Prevalence of Barth Syndrome in the Pediatric Population"],"prefix":"10.1016","volume":"217","author":[{"given":"Paighton C.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schlame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin K.L.","family":"Phoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2019.09.074_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ajmg.c.31372","article-title":"Barth syndrome","volume":"163c","author":"Jefferies","year":"2013","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.jpeds.2019.09.074_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chemphyslip.2015.09.005","article-title":"Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome","volume":"193","author":"Gaspard","year":"2015","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.jpeds.2019.09.074_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11745-016-4229-7","article-title":"Barth Syndrome: connecting cardiolipin to cardiomyopathy","volume":"52","author":"Ikon","year":"2017","journal-title":"Lipids"},{"key":"10.1016\/j.jpeds.2019.09.074_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jpeds.2019.09.074_bib5","series-title":"The voice of the patient: Barth Syndrome","author":"Bowen","year":"2019"},{"key":"10.1016\/j.jpeds.2019.09.074_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1373\/clinchem.2007.095711","article-title":"Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome","volume":"54","author":"Kulik","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.jpeds.2019.09.074_bib7","first-page":"2236","article-title":"Estimating the burden of scleroderma disease in Spain","volume":"34","author":"Villaverde-Hueso","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpeds.2019.09.074_bib8","series-title":"Update on 2004 Background Paper 6.19 Rare Diseases. Priority Medicines for Europe and the World","author":"de Vrueh","year":"2013"},{"key":"10.1016\/j.jpeds.2019.09.074_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13023-014-0173-x","article-title":"A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases","volume":"9","author":"Leadley","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jpeds.2019.09.074_bib10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/qjmed\/hcr116","article-title":"Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis","volume":"104","author":"Harknett","year":"2011","journal-title":"QJM"},{"key":"10.1016\/j.jpeds.2019.09.074_bib11","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jpeds.2019.09.074_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00403-014-1531-1","article-title":"Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid","volume":"307","author":"Alpsoy","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jpeds.2019.09.074_bib13","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/ajmg.a.35609","article-title":"The Barth Syndrome Registry: distinguishing disease characteristics and growth data from a longitudinal study","volume":"158a","author":"Roberts","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2019.09.074_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymgme.2012.01.015","article-title":"Barth syndrome in a female patient","volume":"106","author":"Cosson","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2019.09.074_bib15","series-title":"Females with Barth syndrome Clearwater","author":"Steward","year":"2018"},{"key":"10.1016\/j.jpeds.2019.09.074_bib16","series-title":"Barth Syndrome Registry and Repository","author":"Toth","year":"2019"},{"key":"10.1016\/j.jpeds.2019.09.074_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jval.2018.03.002","article-title":"The problem of rarity: estimation of prevalence in rare disease","volume":"21","author":"Auvin","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.jpeds.2019.09.074_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ajmg.a.20660","article-title":"X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update","volume":"126a","author":"Barth","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2019.09.074_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCRESAHA.116.309386","article-title":"Pediatric cardiomyopathies","volume":"121","author":"Lee","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jpeds.2019.09.074_bib21","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The incidence of pediatric cardiomyopathy in two regions of the United States","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2019.09.074_bib22","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2019.09.074_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.hfc.2010.05.002","article-title":"The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years","volume":"6","author":"Wilkinson","year":"2010","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jpeds.2019.09.074_bib24","first-page":"e18","article-title":"Heart disease and stroke statistics--2011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2019.09.074_bib25","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2018.08.2171","article-title":"Genetic basis of severe childhood-onset cardiomyopathies","volume":"72","author":"Vasilescu","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2019.09.074_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/oxfordjournals.aje.a009291","article-title":"Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland","volume":"146","author":"Arola","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jpeds.2019.09.074_bib27","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2019.09.074_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001735","article-title":"Genetic testing in pediatric left ventricular noncompaction","volume":"10","author":"Miller","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jpeds.2019.09.074_bib29","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/pd.2599","article-title":"Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth","volume":"30","author":"Steward","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jpeds.2019.09.074_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13023-016-0562-4","article-title":"Identification of TAZ mutations in pediatric patients with cardiomyopathy by targeted next-generation sequencing in a Chinese cohort","volume":"12","author":"Wang","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jpeds.2019.09.074_bib31","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1253\/circj.CJ-18-0470","article-title":"Clinical and Echocardiographic impact of tafazzin variants on dilated cardiomyopathy phenotype in left ventricular non-compaction patients in early infancy","volume":"82","author":"Hirono","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jpeds.2019.09.074_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006210","article-title":"A Wide and specific spectrum of genetic variants and genotype-phenotype correlations revealed by next-generation sequencing in patients with left ventricular noncompaction","volume":"6","author":"Wang","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jpeds.2019.09.074_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3892\/ijmm.2017.2986","article-title":"Identification of a novel hypertrophic cardiomyopathy-associated mutation using targeted next-generation sequencing","volume":"40","author":"Zhao","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jpeds.2019.09.074_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1172-8-70","article-title":"Natural history of Barth syndrome: a national cohort study of 22 patients","volume":"8","author":"Rigaud","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jpeds.2019.09.074_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00246-015-1260-z","article-title":"Clinical characteristics and outcomes of cardiomyopathy in Barth Syndrome: the UK experience","volume":"37","author":"Kang","year":"2016","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jpeds.2019.09.074_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MOH.0000000000000472","article-title":"Neutropenia in Barth syndrome: characteristics, risks, and management","volume":"26","author":"Steward","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jpeds.2019.09.074_bib37","series-title":"Summarized findings from the Barth registry interviews: Key points for moving forward","author":"Aiudi","year":"2018"},{"key":"10.1016\/j.jpeds.2019.09.074_bib38","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jmg.2011.089821","article-title":"Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations","volume":"48","author":"Tsangaris","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.jpeds.2019.09.074_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2141.2012.09171.x","article-title":"Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome\/leukaemia","volume":"158","author":"Carlsson","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpeds.2019.09.074_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2012.11.003","article-title":"Epidemiology of congenital neutropenia","volume":"27","author":"Donadieu","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jpeds.2019.09.074_bib41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jfma.2010.12.003","article-title":"Clinical manifestations and outcomes of pediatric chronic neutropenia","volume":"111","author":"Wan","year":"2012","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jpeds.2019.09.074_bib42","series-title":"Barth syndrome","author":"NIH","year":"2019"},{"key":"10.1016\/j.jpeds.2019.09.074_bib43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MOP.0000000000000535","article-title":"Pediatric mitochondrial diseases and the heart","volume":"29","author":"Enns","year":"2017","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jpeds.2019.09.074_bib44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cardfail.2012.01.013","article-title":"Genetic testing for dilated cardiomyopathy in clinical practice","volume":"18","author":"Lakdawala","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jpeds.2019.09.074_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/aqw025","article-title":"Prospective and retrospective diagnosis of Barth syndrome aided by next-generation sequencing","volume":"145","author":"Brion","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jpeds.2019.09.074_bib46","series-title":"Treatment of Barth Syndrome by CARDIOlipin MANipulation (CARDIOMAN): A randomised placebo controlled pilot trial conducted by the nationally commissioned Barth Syndrome Service","author":"Steward","year":"2019"},{"key":"10.1016\/j.jpeds.2019.09.074_bib47","article-title":"Abstract 16368: Elamipretide (ELAM) in Subjects With Barth Syndrome (TAZPOWER): a phase 2 randomized, double-blind, placebo-controlled crossover trial followed by an open-label treatment extension","volume":"138","author":"Vernon","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2019.09.074_bib48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3476(99)70126-5","article-title":"Genetic analysis of the G4.5 gene in families with suspected Barth syndrome","volume":"135","author":"Cantlay","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.09.074_bib49","unstructured":"McKusick VA E. The Johns Hopkins University. Barth Syndrome; BTHS. Entry Number; 302060. Online Mendelian Inheritance in Man (OMIM)."},{"key":"10.1016\/j.jpeds.2019.09.074_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ajmg.1320500309","article-title":"Barth syndrome: clinical observations and genetic linkage studies","volume":"50","author":"Christodoulou","year":"1994","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jpeds.2019.09.074_bib51","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1093\/eurheartj\/ehx545","article-title":"Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy","volume":"38","author":"Sedaghat-Hamedani","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jpeds.2019.09.074_bib52","doi-asserted-by":"crossref","first-page":"e002500","DOI":"10.1161\/CIRCGEN.119.002500","article-title":"Whole exome sequencing reveals a large genetic heterogeneity and revisits the causes of hypertrophic cardiomyopathy","volume":"12","author":"Nguyen","year":"2019","journal-title":"Circ Genomd Prec Med"},{"key":"10.1016\/j.jpeds.2019.09.074_bib53","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ehf2.12420","article-title":"Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy","volume":"6","author":"Jaaskelainen","year":"2019","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.jpeds.2019.09.074_bib54","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","article-title":"The incidence of congenital heart disease","volume":"39","author":"Hoffman","year":"2002","journal-title":"J Am Coll Cardiol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347619313101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347619313101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:02:54Z","timestamp":1758358974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347619313101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":53,"alternative-id":["S0022347619313101"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.09.074","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Bayesian Analysis to Determine the Prevalence of Barth Syndrome in the Pediatric Population","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.09.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}